Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity

5 Nov 2020

Abstract excerpt

Alzheimer's disease (AD) is the most common form of neurodegeneration and dementia. The endocannabinoid (ECB) system has been proposed as a novel therapeutic target to treat AD. The present study explores the expression of the ECB system, the ECB-related receptor GPR55, and cognitive functions (novel object recognition; NOR) in the 5xFAD (FAD: family Alzheimer's disease) transgenic mouse model of AD. Experiments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to Neuroscience and Neuropharmacology Research
Share to Sleep and Wakefulness Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33167441
DOI: 10.3390/biology9110377

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic OpportunityPMID 33167441Read ↗

Cannabidiol and Alzheimer disease: A Comprehensive Review and In Silico Insights into Molecular InteractionsSemantic proximity Read ↗

Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.Semantic proximity Read ↗

An enquiry to the role of CB1 receptors in neurodegenerationSemantic proximity Read ↗

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.Semantic proximity Read ↗

Cannabinoid Type 1 Receptor Antagonist Impaired Spatial Memory and Increased the Tau Gene Expression in Animal Model of the Alzheimer's diseaseSemantic proximity Read ↗

The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut MicrobiotaSemantic proximity Read ↗

Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlSemantic proximity Read ↗

Glial and BBB modifications correlate with early anxio-depressive-like behaviors and cognitive inflexibility in 3xTg-AD miceSemantic proximity Read ↗

Sex- and APOE ε4-dependent expression patterns of the Cannabinoid Receptor-1, FAAH, and MAGL are weakened in late-onset Alzheimer disease frontocortical samplesSemantic proximity Read ↗

Molecular reorganization of endocannabinoid signalling in Alzheimer’s diseaseSemantic proximity Read ↗

Differences in the co-distribution of the Cannabinoid Receptor-1, FAAH, and MAGL in the human and mouse brain could be limiting clinical translation of endocannabinoid outcomes in mouse models of Alzheimer diseaseSemantic proximity Read ↗

Deletion of the γ-secretase subunits Aph1B/C impairs memory and worsens the deficits of knock-in mice modeling the Alzheimer-like familial Danish dementia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.